Gastric Cancer Recurrent

Recurrent gastric cancer occurs when stomach cancer returns after successful treatment. Although the overall recurrence rate after curative surgery is about 20.5%, understanding the patterns and risk factors of recurrence can help guide ongoing care and surveillance strategies.

Table of contents

• Understanding Recurrent Gastric Cancer
• When Recurrence Happens: Timing and Patterns
• Risk Factors for Recurrence
• Types and Locations of Recurrence
• Treatment Options for Recurrent Disease
• The Importance of Follow-Up Care

Understanding Recurrent Gastric Cancer

Recurrent gastric cancer means that stomach cancer has come back after treatment that was intended to remove all cancer from the body. This can happen even when surgery appears to have been successful in removing all visible cancer. Small groups of cancer cells that remain in the body may be too small to detect but can grow over time until they become visible on tests or cause symptoms^[1].

The cancer can return in different ways. It may come back near the original tumor site (called locoregional recurrence), in nearby lymph nodes (called regional recurrence), or in distant organs like the liver or lungs (called distant metastasis)^[1][4]. Understanding where and when cancer might return helps doctors plan the best monitoring and treatment strategies.

When Recurrence Happens: Timing and Patterns

Medical research divides recurrence into three time periods based on when it occurs after surgery. Early recurrence happens within 2 years after surgery, intermediate recurrence occurs between 2 and 5 years, and late recurrence is diagnosed more than 5 years after the initial treatment^[1][5].

Among patients who undergo curative surgery for gastric cancer, about 20.5% experience recurrence at some point during follow-up. Of these recurrences, the majority happen early: about 68% occur within the first 2 years, approximately 23% between 2 and 5 years, and 8.6% after 5 years^[1][5]. Most recurrences are detected within the first few years after treatment, making this period particularly important for close monitoring.

Research shows that up to 30-50% of gastric cancer patients worldwide may experience recurrence within 2-3 years after curative treatment, with rates varying depending on the stage and type of cancer^[14]. The first two to three years after treatment represent the highest-risk period for cancer returning.

Risk Factors for Recurrence

Several factors can increase the likelihood that gastric cancer will return after treatment. Understanding these risk factors helps identify which patients need more intensive follow-up care.

The most important risk factors include the stage of cancer at diagnosis, whether cancer had spread to lymph nodes, the depth of tumor invasion into the stomach wall, and whether the surgery achieved clean margins (meaning all cancer was removed)^[1][4]. Other factors that influence recurrence risk include whether cancer cells were found in lymphatic vessels or nerves, the size of the tumor, and the tumor’s location in the stomach^[1].

For late recurrence specifically (occurring more than 5 years after surgery), younger age at diagnosis and larger tumor size are independent risk factors. This means that younger patients and those with larger tumors at diagnosis need longer-term follow-up care, even if several years have passed since their treatment^[1][5].

Interestingly, patients with recurrent disease after initial curative treatment may have different outcomes than those diagnosed with advanced cancer from the start. Studies show that patients with recurrent metastatic gastric cancer tend to have longer survival times and duration of chemotherapy treatment compared to patients whose cancer was advanced at initial diagnosis^[14].

Types and Locations of Recurrence

When gastric cancer returns, it can appear in different locations, and the pattern of recurrence can vary depending on how long after surgery it occurs.

For patients who experience late recurrence (more than 5 years after surgery), the most common patterns are locoregional spread, which occurs in about 43.5% of cases, and peritoneal seeding (cancer spreading to the lining of the abdominal cavity), which happens in about 34.8% of cases. Less common are spread through the bloodstream to distant organs like the liver or lungs (about 8.7% of cases) and cancer appearing in multiple sites at once (about 13% of cases)^[1][5].

These patterns are important because they influence treatment decisions. Locoregional and peritoneal recurrences are significantly more common than distant spread for late recurrences, which means follow-up surveillance should focus particularly on these areas^[1][5].

Treatment Options for Recurrent Disease

Chemotherapy is usually the main treatment offered for stage 4 or recurrent stomach cancer. It helps shrink the tumor and control cancer growth. Chemotherapy may be given as a single drug or as a combination of different drugs. Common medications include fluorouracil (also called 5-fluorouracil or 5-FU) and capecitabine^[8][10].

Targeted therapy is another treatment option that may be offered along with chemotherapy. These therapies work by targeting specific proteins or characteristics of cancer cells. For example, trastuzumab may be used for cancers that make too much of a protein called HER2. Other targeted therapies like ramucirumab, nivolumab, pembrolizumab, and zolbetuximab may be options depending on the specific characteristics of the cancer^[8][10].

Surgery may sometimes be offered for recurrent stomach cancer, but usually not to try to cure the disease. Instead, surgery is used to relieve symptoms caused by advanced cancer, such as bleeding, blockage, or pain. This is called palliative surgery. Examples include removing the part of the stomach with the tumor, placing a stent (a hollow tube) to help with swallowing, inserting a feeding tube, or relieving bowel obstruction^[8][10].

Radiation therapy may be offered alone or in combination with chemotherapy for recurrent stomach cancer. It is often used to relieve symptoms such as bleeding, pain, difficulty swallowing, or blockage caused by the cancer^[8][10].

Your healthcare team will suggest treatments based on your specific needs and the treatments you have already received. They will work with you to develop a treatment plan that considers your overall health, the location and extent of the cancer recurrence, and your personal preferences^[8][10].

The Importance of Follow-Up Care

Regular follow-up care after completing treatment for gastric cancer is essential for catching any recurrence early. Follow-up appointments are typically scheduled every 3 to 6 months for the first few years after treatment^[3][17].

During these visits, your doctor will perform physical examinations and review any symptoms or health problems you are experiencing. Depending on your situation, follow-up care may include screening tests such as upper endoscopy or imaging tests like CT scans^[3][17].

As time passes without signs of recurrence, the frequency of appointments typically decreases. After the first two years, visits might be scheduled every 6 to 12 months until five years after treatment. After five years, if there are no signs of recurrence, annual visits may be sufficient^[3][17].

Given that late recurrence can occur more than 5 years after surgery, especially in younger patients and those with larger tumors, long-term follow-up care is recommended. The focus should be on detecting locoregional and peritoneal recurrence, as these are the most common patterns of late recurrence^[1][5].

Beyond watching for recurrence, follow-up care also addresses other important aspects of life after cancer treatment. This includes managing any long-term or late side effects from treatment, monitoring for second cancers, and supporting your overall physical and emotional health^[3][17].